CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01254370
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:11.989936+00:00
Published At: 2016-06-06T00:00:00+00:00
Record Updated At: 2016-06-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Glaucoma", "Ocular Hypertension", "Ocular Surface Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-06-06"
protocolSection.identificationModule.nctId: "NCT01254370"
protocolSection.identificationModule.officialTitle: "A Phase 2, Randomized Study Evaluating the Safety and Efficacy of Catioprost\u00ae (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z\u00ae in Subjects With Glaucoma or Ocular Hypertension and Ocular Surface Disease"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.